ResTORbio Pins Hopes On Parkinson’s After Failed CSRI Study

Investors Seem Wary Of Its Prospects, However

 
• By Leah Samuel
  
Desperate businessmen
RTB101 failed first trial, second trial stopped • Source: Shutterstock

More from Clinical Trials

More from R&D